Erin K Hertlein

5PUBLICATIONS
18CO-AUTHORS
HaematologyHaematological tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2024
CD37 in acute myeloid leukemia: a novel surface target for drug delivery.

Erin Jeremy, Esthela Artiga, Sara Elgamal

|Aug 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick

|Nov 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.

Sydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer

|Nov 17, 2021
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.

Swagata Goswami, Rajeswaran Mani, Jessica Nunes

|Feb 25, 2021
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.

Timothy L Chen, Bonnie Harrington, Jean Truxall

Pageof 1

Frequent Collaborators

3 joint publications

Shelley Orwick

2 joint publications

Alice S Mims

2 joint publications

Karilyn T Larkin

2 joint publications

Natarajan Muthusamy